|
|
Volumn 1, Issue 1, 2002, Pages 3-
|
|
Dosing in phase II trial of Alzheimer's vaccine suspended.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALZHEIMER DISEASE VACCINE;
AMYLOID BETA PROTEIN;
AN-1792;
ALZHEIMER DISEASE;
ARTICLE;
HUMAN;
IMMUNIZATION;
METHODOLOGY;
PHASE 2 CLINICAL TRIAL;
ALZHEIMER DISEASE;
ALZHEIMER VACCINES;
AMYLOID BETA-PROTEIN;
CLINICAL TRIALS, PHASE II;
HUMANS;
IMMUNIZATION SCHEDULE;
|
|
EID: 0002639884
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(02)00023-6 Document Type: Article |
|
Times cited : (85)
|
|
References (0)
|
